| PUBCHEM ID |
86278272
|
| UNII |
34Y8UFX0SB
|
| Preferred Term |
TENUIFOLISIDE E
|
| CAS |
162901-87-3
|
| INCHIKEY |
ZJJASXKWRABDMH-KEEUXCKKSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC(OC[C@@H]([C@@H]([C@H]([C@@H]1OC(C)=O)O)OC(C)=O)O[C@H]1O[C@](COC(C)=O)([C@@H]1OC(/C=C/c(cc2)cc(OC)c2O)=O)O[C@@H](COC(/C=C/c(cc2OC)cc(OC)c2O)=O)[C@@H]1O)=O
|
| Total Surface Area |
648,43
|
| Relative PSA |
0,38653
|
| TPSA |
294,1
|
| cLogS |
-4,32
|
| MW |
892,81
|
| cLogP |
0,942
|
| H-Acceptors |
22
|
| H-Donors |
4
|
| Ro5 violations |
2
|
| Druglikeness |
-0,72792
|
| DrugScore |
0,275780693120657
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,3265
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,2844
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
1,0943
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
3,361
|
| Carcinogenicity (Three-class) |
Non-required
|
